| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adherence as a Predictor of Glycemic Control Among Adolescents With Type 1 Diabetes: A Retrospective Study Using Real-world Evidence
|
Ibrahim, Sohayla A.
|
|
|
44 |
10 |
p. 1380-1392
|
artikel
|
| 2 |
A Multicenter, Randomized, Double-blind, Active-controlled, Factorial Design, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of Pitavastatin and Ezetimibe Versus Monotherapy of Pitavastatin in Patients With Primary Hypercholesterolemia
|
Jeong, Han Saem
|
|
|
44 |
10 |
p. 1310-1325
|
artikel
|
| 3 |
Cardiac Autonomic Neuropathy in Type 1 and 2 Diabetes: Epidemiology, Pathophysiology, and Management
|
Williams, Scott
|
|
|
44 |
10 |
p. 1394-1416
|
artikel
|
| 4 |
Dual Therapy for Dyslipidemia: When Two May Be Better Than One
|
Maron, Jill L.
|
|
|
44 |
10 |
p. 1269-1270
|
artikel
|
| 5 |
Editorial Board
|
|
|
|
44 |
10 |
p. ii-iii
|
artikel
|
| 6 |
Effect of 1PC111, a Fixed-dose Combination of Pitavastatin and Ezetimibe, Versus Pitavastatin or Ezetimibe Monotherapy on Lipid Profiles in Patients With Hypercholesterolemia or Mixed Dyslipidemia: A Randomized, Double-blind, Multicenter, Phase III Study
|
Chou, Ming-Ting
|
|
|
44 |
10 |
p. 1272-1281
|
artikel
|
| 7 |
Effects of Elobixibat, an Inhibitor of Ileal Bile Acid Transporter, on Glucose and Lipid Metabolism: A Single-arm Pilot Study in Patients with T2DM
|
Yoshinobu, Satoko
|
|
|
44 |
10 |
p. 1418-1426
|
artikel
|
| 8 |
Efficacy and Tolerability of Ezetimibe/Atorvastatin Fixed-dose Combination Versus Atorvastatin Monotherapy in Hypercholesterolemia: A Phase III, Randomized, Active-controlled Study in Chinese Patients
|
Qian, Juying
|
|
|
44 |
10 |
p. 1282-1296
|
artikel
|
| 9 |
Impact of Respiratory Viral Panel Results on Piperacillin-Tazobactam Use in a Medical Intensive Care Unit: A Single-Center Retrospective Study
|
Pichlinski, Elisa M.
|
|
|
44 |
10 |
p. e97-e103
|
artikel
|
| 10 |
Pharmacokinetics and Safety of Sodium Benzoate, a d-Amino Acid Oxidase (DAAO) Inhibitor, in Healthy Subjects: A Phase I, Open-label Study
|
Lin, Yen-Shan
|
|
|
44 |
10 |
p. 1326-1335
|
artikel
|
| 11 |
Population Pharmacokinetics and Exposure–Response Analyses of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease
|
Adedokun, Omoniyi J.
|
|
|
44 |
10 |
p. 1336-1355
|
artikel
|
| 12 |
Risk Assessment of Major Adverse Cardiovascular and Cerebrovascular Events and Bleeding for Acute Myocardial Infarction With or Without Active Tuberculosis
|
Xu, Xiaoqun
|
|
|
44 |
10 |
p. 1370-1379
|
artikel
|
| 13 |
Solriamfetol Titration & AdministRaTion (START) in Patients With Narcolepsy
|
Thorpy, Michael J.
|
|
|
44 |
10 |
p. 1356-1369
|
artikel
|
| 14 |
Table of Contents
|
|
|
|
44 |
10 |
p. iv-v
|
artikel
|
| 15 |
The First Report of a Real-world Experience With a PCSK9 Inhibitor in a Large Familial Hyperlipidemia and Very-high-risk Middle Eastern Population
|
Iqbal, Sajid
|
|
|
44 |
10 |
p. 1297-1309
|
artikel
|
Tijdschrift beschrijving